Project: Replication fork protector dependency factors: novel targets for combination treatment and immunomodulation in neuroblastoma (REINFORCE)
2022-01-01 – 2025-12-31
- Abstract
This study aims to identify and explore novel therapeutic targets for combination therapy and immunomodulation in neuroblastoma, a pediatric tumor of the developing peripheral nervous system. The teams will collaboratively apply novel technology in functional cancer genetics, oncoimmunology, animal modeling and liquid biopsy analysis. This program will yield novel therapeutic strategies with better survival and reduced adverse side effects.
Show
Sort by
-
- Journal Article
- A1
- open access
NBAtlas : a harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors
-
- Journal Article
- A1
- open access
Characterizing the cell-free transcriptome in a humanized diffuse large B-cell lymphoma patient-derived tumor xenograft model for RNA-based liquid biopsy in a preclinical setting
-
- Journal Article
- A2
- open access
Leveraging a self-cleaving peptide for tailored control in proximity labeling proteomics
-
- Journal Article
- A2
- open access
Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma
-
- Journal Article
- A1
- open access
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
-
- Journal Article
- A1
- open access
RNA extraction method impacts quality metrics and sequencing results in formalin-fixed, paraffin-embedded tissue samples
-
- Journal Article
- A2
- open access
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA
-
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition